Drug Pipeline

Efruxifermin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Phase 3
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-04 NCT06215716
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic…		 Trial sites expanded: 349 -> 355 locations
2026-05-19 NCT06528314
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH		 Trial sites expanded: 318 -> 321 locations
Active Studies by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06215716 A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic… NASH With Fibrosis Recruiting
NCT06528314 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH NASH - Nonalcoholic Steatohepatitis Recruiting
NCT06161571 A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic… NASH/MASH Active, Not Recruiting
Sponsors Running Efruxifermin Trials
Akero Therapeutics, Inc (3)
Disease Areas
NASH / MASH (3)
Get alerts when Efruxifermin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free